Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-03-01 @ 9:57 AM
Study NCT ID:
NCT02701205
Status:
UNKNOWN
Last Update Posted:
2016-03-08
First Post:
2016-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Sponsor:
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2017-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-02-28
First Submit QC Date:
None
Study First Post Date:
2016-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-07
Last Update Post Date:
2016-03-08
Last Update Post Date Type:
ESTIMATED